B-lymphoblastic leukemia/lymphoma with BCR::ABL1-like features exhibits a CRLF2 gene rearrangement in 50% of cases, leading to an overexpression of CRLF2 protein, which can be assessed by flow cytometric analysis. The gene discussed is BCR; the disease is lymphoma.